Showing results (281-290 of 461) with videos related to
Sort By:
Pageof 47
Oncotarget|June 10, 2011
p21-activated kinase 1: PAK'ed with potentialChristy C Ong, Adrian M Jubb, Wei Zhou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trialMichael I Koukourakis, Søren M Bentzen, Alexandra Giatromanolaki, et al.International Journal of Cancer|January 18, 2003
GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole bindingRachel E Airley, Juliette Loncaster, James A Raleigh, et al.Cancer Research|March 13, 2002
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancerNigel J P Beasley, Remko Prevo, Suneale Banerji, et al.Communications Biology|January 5, 2021
Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancerMarcin Paczkowski, Warren W Kretzschmar, Bostjan Markelc, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancerNilay S Patel, Michael S Dobbie, Mark Rochester, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2017
Single-cell heterogeneity in ductal carcinoma in situ of breastMichael J Gerdes, Yesim Gökmen-Polar, Yunxia Sui, et al.Oncotarget|May 24, 2017
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activationSofia Nascimento Dos Santos, Helen Sheldon, Jonathas Xavier Pereira, et al.Clinical & Experimental Metastasis|October 11, 2011
Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survivalAlexandra Giatromanolaki, Efthimios Sivridis, Nikolaos E Bechrakis, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial designDaniele Generali, Alfredo Berruti, Chiara Foroni, et al.Pageof 47